Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlyle (CG) Liabilities and Shareholders Equity (2016 - 2025)

Carlyle (CG) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $29.1 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 26.02% year-over-year to $29.1 billion; the TTM value through Dec 2025 reached $105.3 billion, up 58.13%, while the annual FY2025 figure was $29.1 billion, 26.02% up from the prior year.
  • Liabilities and Shareholders Equity reached $29.1 billion in Q4 2025 per CG's latest filing, up from $27.1 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $29.1 billion in Q4 2025 and bottomed at $8.8 billion in Q2 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $21.6 billion, with a median of $21.4 billion recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 46.38% in 2021, then tumbled 58.86% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $21.3 billion in 2021, then rose by 0.72% to $21.4 billion in 2022, then dropped by 1.06% to $21.2 billion in 2023, then increased by 9.1% to $23.1 billion in 2024, then increased by 26.02% to $29.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $29.1 billion in Q4 2025, $27.1 billion in Q3 2025, and $25.1 billion in Q2 2025.